Track the 일동제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 일동제약 has published 29 public disclosures. The latest transaction was reported on 25 February 2026 (Other). Among the most active insiders: 디비일동베스트제삼차. Every trade is free.
29
Insider Decl.
n/a
Thresholds
n/a
23 ops.
Buy Volume
n/a
4 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.